Whalegun
Home

Jeffrey B. Landau, Chief Business Officer: CytomX Therapeutics CTMX Sell · Filed 23/09/22

Trade details

Type
Insider sale
Amount
$5,354.7
Shares · price
4,119 sh · $1.30 a share
Held after
76,379 sh
Stock
CytomX Therapeutics CTMX
Person
Jeffrey B. LandauChief Business Officer
Trade date
23/09/22
Filed
23/09/22
Days to filing
0 days

Sold 5.1% of holdings

Share of holding sold
5.1%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/23~23/10/22

Jeffrey B. Landau's recent trades

  • Jeffrey B. Landau

    SellCytomX Therapeutics

    $5,143

    Filed 24/08/22

  • Jeffrey B. Landau

    SellCytomX Therapeutics

    $13.7K

    Filed 24/03/21

  • Jeffrey B. Landau

    SellCytomX Therapeutics

    $5,626

    Filed 23/12/22

  • Jeffrey B. Landau

    SellCytomX Therapeutics

    $2,924

    Filed 23/03/20